inside tracker
inside tracker

Nanotech

Longevity companies to watch in 2021

As the world enters the new year with a vaccine and an increased focus on geroprotection, there’s much to look forward to. Research from the...

A year in Longevity: different perspectives

Looking for anti-aging solutions in some unusual places. 2020 has seen Longevity.Technology covering a variety of news in the Longevity sector, from discoveries in the...

Neurotech2020 – a clear head for neurotech, research and investment

Tomorrow's dreams today ... well, next week – it's Neurotech2020. Neurotech2020 – the digital congress for neurotechnology innovation and growth – is coming to (your...

Longevity boost as nanotech reveals inner cell workings

A ground-breaking discovery is taking researchers deep into the heart of cells, allowing them to measure even the tiniest movements. Scientists have for the...

The natural medicine war chest to fight aging

Quicksilver's liposomal delivery system boasts a non-invasion of the body patchers. Colorado-based Quicksilver Scientific manufactures a range of supplements from immunity boosters to NAD+. By...

Astellas to acquire iota Biosciences

Following an R&D collaboration that began last year, Japanese pharma Astellas has announced it will acquire bioelectronics firm iota in $304m deal. Last year's R&D...

Neurotech2020: It’s a brave new world

It's an online conference, but not as you know it. Say goodbye to Zoom fatigue and hello to Neurotech2020. Understanding the brain, consciousness and thought...

Deliver us from aging – the Quicksilver method

Bigger certainly doesn't mean better when it comes to Quicksilver's nutraceutical delivery methods. The COVID-19 pandemic has caused an upturn in the supplements industry; from...

The X-factor required for bio-printed growth success

Bio-printed implants, optimised with growth factors, show promise in the repair of bone defects, tissue regeneration and vascularisation. A number of recent studies have demonstrated...

Cancer blood test maker Grail files for Nasdaq IPO

Grail is on a quest for early cancer detection; the company is going public after raising nearly $2b in funding for its development of...

Cutting surgical robots down to size

A new microsurgical robot shows promise in performing highly complex and delicate operations and can even outperform human surgeons. A new robot using an innovative...

Nanotech ‘passport to the brain’ for therapeutics

Researchers discover a new nanotech approach to deliver therapies through the blood-brain barrier. Scientists at Tufts University have discovered a way to deliver therapeutics safely...

Nanoparticles target immune response using red blood cells

Polystyrene nanoparticles deliver drug payload directly to the spleen and bypass lengthy clinical trial requirements. Vaccines are making headlines at the moment, for obvious reasons, ...

When scaling down is as vital as scaling up

Robotics continue to scale down - but can researchers include the autonomy necessary for the medical intervention that will prolong life? Tiny robots could be...

NaNotics raising Series B to support Asia-Pacific trials

NaNotics nano particles could revolutionise of a host of chronic and acute conditions. Louis Hawthorne, CEO of NaNotics, has released an 11 minute video aimed...

Hydrogel scaffold raises hopes for tissue regeneration

Wyss Institute hydrogel therapy can repair nerves, muscles and blood vessels. Naturally-occurring molecules VEGF and IGF-1 can enhance tissue regrowth and repair, but getting them...

‘Internet of the body’ device to regulate genes externally

Bioelectric remote control of cell signalling drives synthetic biology progress: tests trigger bioengineered cells to release insulin. A team at the Department of Biosystems Science and...

Novel approach breaks through blood-brain barrier

Molecular transport is on target for shuttling therapies directly into the brain. Like an exclusive nightclub, the brain has the best bouncer in the business....

Building an artificial immune system

DoD-funded ThirdLaw Technologies to harness the power of ‘spiroligomers’ to rapidly build new small molecules for Longevity therapies. Far from the world of stock market...

Longevity and the Singularity

Consciousness in the cloud? Where science fact and fiction collide. While the principle focus of Longevity is undoubtedly the extension of healthy human lifespan, there...
inside tracker
lumen

Latest articles